Rheumatology 1
Rheumatology 2
Rheumatology 3
Rheumatology 4
Rheumatology 5
100

Major benefit of NSAIDs in RA

Symptom control

100

Nonpharmacologic fibromyalgia therapy

Disease education, aerobic exercise, psychosocial support

100

Drug therapy for all patients with SLE without contraindications

Hydroxychloroquine

100

Common sites of enthesitis in psoriatic arthritis

Achilles tendon, plantar fascia

100

Gastrointestinal pathogens associated with reactive arthritis

Salmonella, Shigella, Campylobacter, Yersinia

200

Most specific serologic test for RA

Anti–cyclic citrullinated peptide antibody

200

SNRIs approved for fibromyalgia

Duloxetine and milnacipran

200

Skin rash in reactive arthritis

Keratoderma blennorrhagicum

200

Rheumatologic diseases most commonly associated with secondary Sjögren disease

RA and SLE

200

An infectious cause of mixed cryoglobulinemia

Hepatitis C virus infection

300

Treatment of suspected giant cell arteritis

Immediate high-dose glucocorticoids

300

Late RA radiographic findings of hands and/or feet

Periarticular osteopenia, marginal erosions, joint-space narrowing

300

SLE-related annular rash with central clearing or erythematous plaques and papules

Subacute cutaneous lupus erythematosus

300

Cause of airway obstruction in relapsing polychondritis

Involvement of tracheal rings

300

Coadministration with colchicine reduces hepatic catabolism and could lead to colchicine overdose

CYP3A4 inhibitors (such as clarithromycin)

400

Major cause of excess death in patients with RA

Coronary artery disease

400

Major cause of death in mixed connective tissue disease

Pulmonary arterial hypertension

400

Rheumatologic conditions associated with higher risk for coexistent fibromyalgia

Sjögren disease, SLE, rheumatoid arthritis

400

Insidious onset of proximal and distal symmetric muscle weakness

Inclusion body myositis

400

GI disease risk in patients with ankylosing spondylitis

IBD

500

Most effective maintenance therapy in granulomatosis with polyangiitis

Rituximab

500

Definitive knee OA therapy after failure of conservative measures

Knee joint replacement

500

Acute severe myopathy and anti–HMG Co-A reductase antibodies

Immune-mediated necrotizing myopathy

500

External ear redness and swelling without ear lobe involvement

Relapsing polychondritis

500

Inflammatory marker that may be normal in active SLE

C-reactive protein